APR 27, 2017 2:36 PM PDT

Technique Prevents Graft-Versus-Host Disease

WRITTEN BY: Xuan Pham

Bone marrow transplants are often considered to be the last resort treatment, because the procedure could have the nearly same chance of saving a patient as it does harming the patient. But now, scientists at the City of Hope say they have found a way to make the procedure safer for patients.

For patients with leukemia or lymphoma, a stem cell or bone marrow transplant is considered the only curative therapy. The procedure replaces a patient’s diseased blood stem cells with healthy ones from a matched donor. But in some cases, the donor’s cells can attack the recipient’s health tissues, and can cause tremendous multiple organ complications. This attack is known as graft-versus-host disease (GVHD).

"Currently, immunosuppressive drugs have been used to prevent GVHD, but immune-suppressants also subdue the anti-cancer effects of the donor T cells, potentially resulting in cancer relapse, in addition to other side effects such as an increased risk of infection," said Defu Zeng, who led the international collaboration at the City of Hope. "Therefore, prevention of GVHD while preserving anti-cancer effects remains the 'holy grail' of allogenic HCT [hematopoietic cell transplantation]." Of note, allogenic HTC refers to using stem cells derived from a donor.

The team report that one way to prevent GVHD is to temporarily deplete a specific type of of donor T cells, called CD4+, following the infusion of stem cells. In the absence of low CD4+ cells, another type of T cells, called CD8+, seems to be more focused on destroying tumor cells rather than the healthy cells. This has the effect of boosting graft-versus-leukemia, while preventing graft-versus-host disease.

"If successfully translated into clinical application, this regimen may represent one of the novel approaches that allow strong GVL effects without causing GVHD," said Zeng. "This kind of regimen has the potential to promote wide-spread application of allogenic HCT as a curative therapy for hematological malignancies."

So far the study has been limited to mouse models. Next, Zeng and colleagues plan to apply this method in human clinical trials.

Additional sources: City of Hope

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 27, 2021
Cardiology
New miRNAs Might Help Diagnose Severe Dilated Cardiomyopathy
APR 27, 2021
New miRNAs Might Help Diagnose Severe Dilated Cardiomyopathy
The heart is one of the most reliable parts of the body. It pumps day and night, delivering fresh oxygen and nutrients t ...
APR 27, 2021
Clinical & Molecular DX
No Batteries: Health Sensor Harvests Biomechanical Energy
APR 27, 2021
No Batteries: Health Sensor Harvests Biomechanical Energy
An international team of researchers has developed a wearable health monitor that works without the need for batteries. ...
MAY 13, 2021
Clinical & Molecular DX
Smart Patch Measures How Itchy You Are
MAY 13, 2021
Smart Patch Measures How Itchy You Are
A wearable “scratch sensor” developed by researchers at Northwestern University could finally help doctors m ...
MAY 18, 2021
Clinical & Molecular DX
A Crystal Ball for Predicting Labor Day
MAY 18, 2021
A Crystal Ball for Predicting Labor Day
Expectant mothers may no longer have to be caught off guard—researchers have identified biomarkers in the blood th ...
AUG 12, 2021
Clinical & Molecular DX
Computers Pick Up the 'Sound' of Thyroid Cancer
AUG 12, 2021
Computers Pick Up the 'Sound' of Thyroid Cancer
Researchers have developed a new technology for the non-invasive diagnosis of thyroid cancer that combines photoacoustic ...
AUG 23, 2021
Clinical & Molecular DX
Better Health Monitoring Protects Nursing Home Residents
AUG 23, 2021
Better Health Monitoring Protects Nursing Home Residents
Residents of nursing homes are particularly susceptible to health complications. Around half of all individuals residing ...
Loading Comments...